[Pooled Human Immunoglobulin Preparations as Immunomodulating Drugs].

Area of Science:

• Immunology
• Therapeutic antibody development

Background:

• Passive immunotherapy has advanced significantly since the first diphtheria antitoxic serum.
• Pooled human immunoglobulin G (IgG) is widely used for immunodeficiency and autoimmune diseases.
• Current IgG preparations contain a diverse antibody repertoire from healthy donors.

Observation:

• Certain protein-modifying agents, such as low-pH buffers, heme, and reactive oxygen species, can induce polyspecificity in IgG.
• Induced polyspecificity allows IgG molecules to bind novel, structurally unrelated antigens.
• Modified IgG preparations demonstrated improved survival rates in animal models of sepsis and systemic inflammation.

Findings:

• Naturally polyspecific antibodies provide a first-line defense against pathogens.
• Induced polyspecificity enhances the antigen-binding capabilities of IgG.
• Therapeutic administration of modified IgG significantly improved outcomes in experimental sepsis and systemic response syndromes.

Implications:

• Modified antibody preparations hold therapeutic potential for inflammatory and infectious diseases.
• Specificity editing of immunoglobulin B cell receptors and T cell receptors by inflammatory molecules may play a role in immune defense.
• Further research into induced polyspecificity could lead to novel immunomodulatory therapies.